Glucotrack, Inc. (GCTK)
2025-06-30 | ||||
---|---|---|---|---|
Foreign currency translation adjustment | 29 | |||
Other (income) expense, net | -96 | |||
Research and development expenses | 3,150 | |||
Marketing expenses | 182 | |||
General and administrative expenses | 1,464 | |||
Total operating expenses | 4,796 | |||
Operating loss | -4,796 | |||
Change in fair value of derivative liabilities | 107 | |||
Finance income, net | 29 | |||
Net loss | -4,756 | |||
Comprehensive loss for the period | -4,727 | |||
Basic net loss per common stock | 9.62 | |||
Diluted net loss per common stock | 9.62 | |||
Weighted average number of common stock used in computing basic loss per common stock | 494,504 | |||
Weighted average number of common stock used in computing diluted loss per common stock | 494,504 |